This is a routine procedural scheduling order with no material impact on Vir Biotechnology's business or stock. Monitor for any substantive rulings or settlement developments after the November 2026 mediation deadline.
VIR drugs
VIR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 17 $9.39entry
- T+1 · 3mo ago +1.06%α +1.74% · $9.49
- T+5 · 3mo ago +5.54%α +6.73% · $9.91
- T+20 · 2mo ago +11.18%α +13.16% · $10.44
- T+60 · 7d ago +45.31%α +48.08% · $13.65
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A joint stipulation in Smith v. Vir Biotechnology, Inc. was approved by the court, extending the mediation deadline from August 13, 2026 to November 30, 2026 to allow additional time for discovery. This is a routine procedural scheduling order with no substantive ruling on the merits of the case, and no financial exposure or business impact is stated in the document.
Court Ruling Details
Key Facts
- The court approved a joint stipulation to extend the mediation deadline from August 13, 2026 to November 30, 2026.
- The extension was requested to allow additional time for initial discovery, document production, and depositions.
- No damages, injunction, or substantive ruling on the merits is present in this order.
Financial Impact
No financial exposure stated in the document.
Risk Factors
- The underlying lawsuit could result in a material adverse outcome if not resolved at mediation, but no details on the claims or potential exposure are provided in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-43c8faf2c0-VIR |
Track record
36 reports on VIR
4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today 424B5 Bearish 5/10 Entry $9.84 Now $9.58 +2.64% settles Nov 23
- Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
- Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
- Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $13.15 Now $9.58 −27.15% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
- Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
- Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers